Hydrogen gas therapy induced shrinkage of metastatic gallbladder cancer: A case report.
Ji-Bing Chen, Zhong-Bao Pan, Duan-Ming Du, Wei Qian, Yang-Yang Ma, Feng Mu, Ke-Cheng Xu · World journal of clinical cases · 2019
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In CASE SUMMARY: The patient refused other treatments and began daily hydrogen inhalation therapy, three months after hydrogen therapy, the metastases in the abdominal cavity gradually reduced in size, her anemia and hypoalbuminemia were corrected, lymphocyte and tumor marker levels returned to normal, and the patient was able to resume normal life.
What the Researchers Studied
Three months after hydrogen therapy, the metastases in the abdominal cavity gradually reduced in size, her anemia and hypoalbuminemia were corrected, lymphocyte and tumor marker levels returned to normal, and the patient was able to resume normal life.
How Molecular Hydrogen Was Used
CASE SUMMARY: The patient refused other treatments and began daily hydrogen inhalation therapy. After continuous hydrogen therapy and symptomatic treatments including gastrointestinal decompression and intravenous nutrition support, the intestinal obstruction was gradually relieved. Three months after hydrogen therapy, the metastases in the abdominal cavity gradually reduced in size, her anemia and hypoalbuminemia were corrected, lymphocyte and tumor marker levels returned to normal, and the patient was able to resume normal life.
What the Researchers Found
Three months after hydrogen therapy, the metastases in the abdominal cavity gradually reduced in size, her anemia and hypoalbuminemia were corrected, lymphocyte and tumor marker levels returned to normal, and the patient was able to resume normal life.
Authors’ Conclusion
The authors concluded that this is the first report of an efficacy and safety study about hydrogen therapy in patient with metastatic GBC and a critical general condition, who has remained stable for more than 4 months.